Sarjan Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 12-12-2024
- Paid Up Capital ₹ 3.09 M
as on 12-12-2024
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 15.16 Cr
as on 12-12-2024
- Revenue 103.24%
(FY 2019)
- Profit 217.65%
(FY 2019)
- Ebitda -379.55%
(FY 2019)
- Net Worth 54.66%
(FY 2019)
- Total Assets 7.05%
(FY 2019)
About Sarjan Nutraceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.09 M.
The company has closed loans amounting to ₹15.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jaykumar Patel and Princekumar Patel serve as directors at the Company.
- CIN/LLPIN
U15490GJ2004PTC045080
- Company No.
045080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2004
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarjan Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaykumar Patel  | Director | 06-Mar-2018 | Current |
| Princekumar Patel | Director | 06-Mar-2018 | Current |
Financial Performance of Sarjan Nutraceuticals.
Sarjan Nutraceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 103.24% increase. The company also saw a substantial improvement in profitability, with a 217.65% increase in profit. The company's net worth Soared by an impressive increase of 54.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarjan Nutraceuticals?
In 2019, Sarjan Nutraceuticals had a promoter holding of 67.56% and a public holding of 32.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Nov 2017 | ₹10.33 Cr | Satisfied |
Others Creation Date: 07 Jul 2016 | ₹1.08 Cr | Satisfied |
The Mahsena Urban Co- Operative Bank Limited Creation Date: 06 Mar 2013 | ₹3.25 Cr | Satisfied |
How Many Employees Work at Sarjan Nutraceuticals?
Unlock and access historical data on people associated with Sarjan Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarjan Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarjan Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
